Literature DB >> 31173873

In utero and postnatal programing of dehydroepiandrosterone sulfate (DHEAS) in young adult women.

Barbara A Cohn1, Piera M Cirillo2.   

Abstract

Fetal adrenal-derived OH-DHEAS is the primary precursor for maternal estriol, an abundant, human, placental estrogen. We measured maternal pregnancy estriol as a marker of fetal adrenal function + placenta capacity to synthesize estriol. We hypothesized that maternal estriol is directly correlated with the adrenal hormone, DHEAS, in young adult women. We tested this hypothesis in a subset of women in the Child Health and Development Studies (351 of 470 eligible). 176 of these had serum samples collected at ages 27-30 for DHEAS assays, archived maternal pregnancy serum for estriol assays, and childhood growth data. In regression analyses, both maternal estriol and accelerated growth in middle childhood were independently, directly associated with DHEAS (+19% for quartile 4 versus quartile 1 of estriol, 95%CI=+ 2%, +36% and +12% for quartile 4 versus quartile 1 for middle childhood growth, 95%CI= +3%, +21%). Adrenal function may be programmed in utero and middle childhood with long-term consequences.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Birth weight; DHEAS; Dehydroepiandrosterone sulfate; Developmental programming; Epidemiology; Estriol; Feto-placental unit; Postnatal weight gain; Pregnancy; Prospective; Young adult

Mesh:

Substances:

Year:  2019        PMID: 31173873     DOI: 10.1016/j.reprotox.2019.05.062

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  2 in total

1.  CHDS: A national treasure that keeps on giving.

Authors:  Suzanne E Fenton; Linda S Birnbaum
Journal:  Reprod Toxicol       Date:  2020-02-22       Impact factor: 3.143

2.  "I'm not a freshi": Culture shock, puberty and growing up as British-Bangladeshi girls.

Authors:  Lauren C Houghton; Rebecca Troisi; Marni Sommer; Hormuzd A Katki; Mark Booth; Osul A Choudhury; Kate R Hampshire
Journal:  Soc Sci Med       Date:  2020-05-21       Impact factor: 4.634

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.